|
1
|
Senturk LM and Imamoglu M: Adenomyosis:
What is new? Womens Health (Lond). 11:717–724. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garcia L and Isaacson K: Adenomyosis:
Review of the literature. J Minim Invasive Gyneco. l18:428–437.
2011. View Article : Google Scholar
|
|
3
|
Zhou S, Yi T, Liu R, Bian C, Qi X, He X,
Wang K, Li J, Zhao X, Huang C and Wei Y: Proteomics identification
of annexin A2 as a key mediator in the metastasis and
proangiogenesis of endometrial cells in human adenomyosis. Mol Cell
Proteomics. 11(M112): 0179882012.PubMed/NCBI
|
|
4
|
Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS
and Ho HN: Altered apoptosis and proliferation in endometrial
stromal cells of women with adenomyosis. Hum Reprod. 22:945–952.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parrott E, Butterworth M, Green A, White
IN and Greaves P: Adenomyosis-a result of disordered stromal
differentiation. Am J Pathol. 159:623–630. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Franco-Chuaire ML, Carolina Magda SC and
Chuaire-Noack L: Epithelial-mesenchymal transition (EMT):
Principles and clinical impact in cancer therapy. Invest Clin.
54:186–205. 2013.PubMed/NCBI
|
|
7
|
Hay ED and Zuk A: Transformations between
epithelium and mesenchyme: Normal, pathological, and experimentally
induced. Am J Kidney Dis. 26:678–690. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Puisieux A, Brabletz T and Caramel J:
Oncogenic roles of EMT-inducing transcription factors. Nat Cell
Biol. 16:488–494. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen YJ, Li HY, Huang CH, Twu NF, Yen MS,
Wang PH, Chou TY, Liu YN, Chao KC and Yang MH: Oestrogen-induced
epithelial-mesenchymal transition of endometrial epithelial cells
contributes to the development of adenomyosis. J Pathol.
222:261–270. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oh SJ, Shin JH, Kim TH, Lee HS, Yoo JY,
Ahn JY, Broaddus RR, Taketo MM, Lydon JP, Leach RE, et al:
β-catenin activation contributes to the pathogenesis of adenomyosis
through epithelial-mesenchymal transition. J Pathol. 231:210–222.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xue J, Zhang H, Liu W, Liu M, Shi M, Wen Z
and Li C: Metformin inhibits growth of eutopic stromal cells from
adenomyotic endometrium via AMPK activation and subsequent
inhibition of AKT phosphorylation: A possible role in the treatment
of adenomyosis. Reproduction. 146:397–406. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao J and Guan JL: Signal transduction by
focal adhesion kinase in cancer. Cancer Metastasis Rev. 28:35–49.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schaller MD: Cellular functions of FAK
kinases: Insight into molecular mechanisms and novel functions. J
Cell Sci. 123:1007–1013. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang LL, Liu J, Lei S, Zhang J, Zhou W
and Yu HG: PTEN inhibits the invasion and metastasis of gastric
cancer via downregulation of FAK expression. Cell Signal.
26:1011–1020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Golubovskaya VM, Ylagan L, Miller A,
Hughes M, Wilson J, Wang D, Brese E, Bshara W, Edge S, Morrison C
and Cance WG: High focal adhesion kinase expression in breast
carcinoma is associated with lymphovascular invasion and
triple-negative phenotype. BMC Cancer. 14:7692014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mael-Ainin M, Abed A, Conway SJ, Dussaule
JC and Chatziantoniou C: Inhibition of periostin expression
protects against the development of renal inflammation and
fibrosis. J Am Soc Nephrol. 25:1724–1736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Avizienyte E and Frame MC: Src and FAK
signalling controls adhesion fate and the epithelial-to-mesenchymal
transition. Curr Opin Cell Biol. 17:542–547. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bouchard V, Demers MJ, Thibodeau S,
Laquerre V, Fujita N, Tsuruo T, Beaulieu JF, Gauthier R, Vézina A,
Villeneuve L, et al: Fak/src signaling in human intestinal
epithelial cell survival and anoikis: Differentiation
state-specific uncoupling with the PI3K/AKT1 and MEK/ERK pathways.
J Cell Physiol. 212:717–728. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mu L, Chen W, Ma Y and Zheng W: Expression
of focal adhesion kinase in the eutopic endometrium of women with
adenomyosis varies with dysmenorrhea and pelvic pain. Exp Ther Med.
10:1903–1907. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao L, Zhou S, Zou L and Zhao X: The
expression and functionality of stromal caveolin 1 in human
adenomyosis. Hum Reprod. 28:1324–1338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang PF, Li KS, Shen YH, Gao PT, Dong ZR,
Cai JB, Zhang C, Huang XY, Tian MX, Hu ZQ, et al: Galectin-1
induces hepatocellular carcinoma EMT and sorafenib resistance by
activating FAK/PI3K/AKT signaling. Cell Death Dis. 7:e22012016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roy-Luzarraga M and Hodivala-Dilke K:
Molecular pathways: Endothelial cell FAK-A target for cancer
treatment. Clin Cancer Res. 22:3718–3724. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parsons JT: Focal adhesion kinase: The
first ten years. J Cell Sci. 116:1409–1416. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mehta D: Focal adhesion kinase regulation
of endothelial barrier function, apoptosis, and neovascularization.
Microvasc Res. 83:1–2. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saito D, Kyakumoto S, Chosa N, Ibi M,
Takahashi N, Okubo N, Sawada S, Ishisaki A and Kamo M: Transforming
growth factor-β1 induces epithelial-mesenchymal transition and
integrin α3β1-mediated cell migration of HSC-4 human squamous cell
carcinoma cells through Slug. J Biochem. 153:303–315. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cicchini C, Laudadio I, Citarella F,
Corazzari M, Steindler C, Conigliaro A, Fantoni A, Amicone L and
Tripodi M: TGFbeta-induced EMT requires focal adhesion kinase (FAK)
signaling. Exp Cell Res. 314:143–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deng B, Yang X, Liu J, He F, Zhu Z and
Zhang C: Focal adhesion kinase mediates TGF-β1-induced renal
tubular epithelial-to-mesenchymal transition in vitro. Mol Cell
Biochem. 340:21–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li XY, Zhou X, Rowe RG, Hu Y, Schlaepfer
DD, Ilić D, Dressler G, Park A, Guan JL and Weiss SJ: Snail1
controls epithelial-mesenchymal lineage commitment in focal
adhesion kinase-null embryonic cells. J Cell Biol. 195:729–738.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Slack-Davis JK, Eblen ST, Zecevic M,
Boerner SA, Tarcsafalvi A, Diaz HB, Marshall MS, Weber MJ, Parsons
JT and Catling AD: PAK1 phosphorylation of MEK1 regulates
fibronectin-stimulated MAPK activation. J Cell Biol. 162:281–291.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Julien S, Puig I, Caretti E, Bonaventure
J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A
and Larue L: Activation of NF-kappaB by Akt upregulates Snail
expression and induces epithelium mesenchyme transition. Oncogene.
26:7445–7456. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hanashi H, Shiokawa S, Akimoto Y, Sakai K,
Sakai K, Suzuki N, Kabir-Salmani M, Nagamatsu S, Iwashita M and
Nakamura Y: Physiologic role of decidual beta1 integrin and focal
adhesion kinase in embryonic implantation. Endocr J. 50:189–198.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livasy CA, Moore D, Cance WG and Lininger
RA: Focal adhesion kinase overexpression in endometrial neoplasia.
Appl Immunohistochem Mol Morphol. 12:342–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mu L, Zheng W, Wang L, Chen X and Yang J:
Focal adhesion kinase expression in ovarian endometriosis. Int J
Gynaecol Obstet. 101:161–165. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gumbiner BM: Regulation of
cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol.
6:622–634. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shapiro L and Weis WI: Structure and
biochemistry of cadherins and catenins. Cold Spring Harb Perspect
Biol. 1:a0030532009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mirantes C, Espinosa I, Ferrer I, Dolcet
X, Prat J and Matias-Guiu X: Epithelial-to-mesenchymal transition
and stem cells in endometrial cancer. Hum Pathol. 44:1973–1981.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Canel M, Serrels A, Frame MC and Brunton
VG: E-cadherin-integrin crosstalk in cancer invasion and
metastasis. J Cell Sci. 126:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Thompson EW and Williams ED: EMT and MET
in carcinoma-clinical observations, regulatory pathways and new
models. Clin Exp Metastasis. 25:591–592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Golubovskaya VM, Finch R and Cance WG:
Direct Interaction of the N-terminal domain of focal adhesion
kinase with the N-terminal transactivation domain of p53. J Biol
Chem. 280:25008–25021. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ferenczy A: Pathophysiology of
adenomyosis. Hum Reprod Update. 4:312–322. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Curtis KM, Hillis SD, Marchbanks PA and
Peterson HB: Disruption of the endometrial-myometrial border during
pregnancy as a risk factor for adenomyosis. Am J Obstet Gynecol.
187:543–544. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yuan H, Meng X, Guo W, Cai P, Li W, Li Q,
Wang W, Sun Y, Xu Q and Gu Y: Transmembrane-bound IL-15-promoted
epithelial-mesenchymal transition in renal cancer cells requires
the Src-dependent Akt/GSK-3β/β-catenin pathway. Neoplasia.
17:410–420. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 30′kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Grille SJ, Bellacosa A, Upson J,
Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and
Larue L: The protein kinase Akt induces epithelial mesenchymal
transition and promotes enhanced motility and invasiveness of
squamous cell carcinoma lines. Cancer Res. 63:2172–2178.
2003.PubMed/NCBI
|
|
49
|
Lee KR, Lee JS, Song JE, Ha SJ and Hong
EK: Inonotus obliquus-derived polysaccharide inhibits the migration
and invasion of human non-small cell lung carcinoma cells via
suppression of MMP-2 and MMP-9. Int J Oncol. 45:2533–2540. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lu M, Marsters S, Ye X, Luis E, Gonzalez L
and Ashkenazi A: E-cadherin couples death receptors to the
cytoskeleton to regulate apoptosis. Mol Cell. 54:987–998. 2014.
View Article : Google Scholar : PubMed/NCBI
|
